Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence.
Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, Fauvet F, Puisieux I, Doglioni C, Piccinin S, Maestro R, Voeltzel T, Selmi A, Valsesia-Wittmann S, Caron de Fromentel C, Puisieux A. Ansieau S, et al. Among authors: caron de fromentel c. Cancer Cell. 2008 Jul 8;14(1):79-89. doi: 10.1016/j.ccr.2008.06.005. Cancer Cell. 2008. PMID: 18598946 Free article.
Cancer stem cells: the emerging challenge of drug targeting.
Besançon R, Valsesia-Wittmann S, Puisieux A, Caron de Fromentel C, Maguer-Satta V. Besançon R, et al. Among authors: caron de fromentel c. Curr Med Chem. 2009;16(4):394-416. doi: 10.2174/092986709787315531. Curr Med Chem. 2009. PMID: 19199913 Review.
TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression.
Ruptier C, De Gaspéris A, Ansieau S, Granjon A, Tanière P, Lafosse I, Shi H, Petitjean A, Taranchon-Clermont E, Tribollet V, Voeltzel T, Scoazec JY, Maguer-Satta V, Puisieux A, Hainaut P, Cavard C, Caron de Fromentel C. Ruptier C, et al. Among authors: caron de fromentel c. Oncogene. 2011 Nov 17;30(46):4656-65. doi: 10.1038/onc.2011.171. Epub 2011 Jun 6. Oncogene. 2011. PMID: 21643019
p53 as a target for anti-cancer drug development.
Bouchet BP, Caron de Fromentel C, Puisieux A, Galmarini CM. Bouchet BP, et al. Among authors: caron de fromentel c. Crit Rev Oncol Hematol. 2006 Jun;58(3):190-207. doi: 10.1016/j.critrevonc.2005.10.005. Epub 2006 May 9. Crit Rev Oncol Hematol. 2006. PMID: 16690321 Review.
46 results